DavidRBetteridgeMD

PubMed

• Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis.
  Boekholdt, S. M.,Arsenault, B. J.,Hovingh, G. K.,Mora, S.,Pedersen, T. R.,Larosa, J. C.,Welch, K. M.,Amarenco, P.,Demicco, D. A.,Tonkin, A. M.,Sullivan, D. R.,Kirby, A...> ;Circulation. 2013 Oct 1
• 35 citations
  The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
  Connie B. Newman, Michael Szarek, Helen M. Colhoun, D. John Betteridge, Paul N. Durrington, Graham A. Hitman, H. Andrew W. Neil, David A. DeMicco, Sheila B. Auster, Jo...> ;Diabetes & Vascular Disease Research. 2008 Sep 1
• 24 citations
  CONFORMATIONAL DYNAMICS OF TROPOMYOSIN IN SOLUTION: EVIDENCE FOR TWO CONFORMATIONAL STATES*
  Sherwin S. Lehrer, Philip Graceffa, David R. Betteridge> ;Annals of the New York Academy of Sciences. 1981 Jun 1
• An improved flow-through phototransducer.
  Sly, T. J., Betteridge, D., Wibberley, D., Porter, D. G.> ;J Automat Chem. 1982 Jan 01
• Computer-controlled apparatus for automated development of continuous flow methods.
  Wentzell, P. D., Hatton, M. J., Shiundu, P. M., Ree, R. M., Wade, A. P., Betteridge, D., Sly, T. J.> ;J Automat Chem. 1989 Jan 01
• Cholesterol is the major atherogenic lipid in NIDDM.
  Betteridge, D.> ;Diabetes Metab Rev. 1997 Jun
• Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuc...
  Soberman, R. J., Harper, T. W., Betteridge, D., Lewis, R. A., Austen, K. F.> ;J Biol Chem. 1985 Apr 10
• Computer-assisted optimization of HPLC with post-column reaction for the determination of amino-acids.
  Al-Najafi, S., Wellington, C. A., Wade, A. P., Sly, T. J., Betteridge, D.> ;Talanta. 1987 Sep 01
• Reflections on the modified simplex-II.
  Betteridge, D., Wade, A. P., Howard, A. G.> ;Talanta. 1985 Aug 01
• Reflections on the modified simplex-I.
  Betteridge, D., Wade, A. P., Howard, A. G.> ;Talanta. 1985 Aug 01
• Non-enzymatic glycosylation of plasma lipoproteins in vitro.
  Smith, C. C., Dickson, A. C., Betteridge, D. J.> ;Diabetes Res. 1985 Nov 01
• The distribution of catecholamines between platelets and plasma in normal human subjects.
  Smith, C. C., Curtis, L. D., Delamothe, A. P., Prichard, B. N., Betteridge, D. J.> ;Clin Sci. 1985 Jul 01
• Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa.
  Stirling, C., McAleer, M., Reckless, J. P., Campbell, R. R., Mundy, D., Betteridge, D. J., Foster, K.> ;Clin Sci. 1985 Jan 01
• Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 dia...
  Colhoun, H. M., Betteridge, D. J., Durrington, P., Hitman, G., Neil, A., Livingstone, S., Charlton-Menys, V., Bao, W., Demicco, D. A., Preston, G. M., Deshmukh, H., Ta...> ;Diabetes. 2011 Sep
• Thiazolidinediones and fracture risk in patients with Type 2 diabetes.
  Betteridge, D. J.> ;Diabet Med. 2011 Jul
• Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.
  Guyton, J. R., Betteridge, D. J., Farnier, M., Leiter, L. A., Lin, J., Shah, A., Johnson-Levonas, A. O., Brudi, P.> ;Diab Vasc Dis Res. 2011 Apr
• High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.
  Ferrannini, E., Betteridge, D. J., Dormandy, J. A., Charbonnel, B., Wilcox, R. G., Spanheimer, R., Erdmann, E., Defronzo, R. A., Laakso, M.> ;Diabetes Obes Metab. 2011 Aug
• Lipid control in patients with diabetes mellitus.
  Betteridge, D. J.> ;Nat Rev Cardiol. 2011 May
• Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of po...
  Leiter, L. A., Betteridge, D. J., Farnier, M., Guyton, J. R., Lin, J., Shah, A., Johnson-Levonas, A. O., Brudi, P.> ;Diabetes Obes Metab. 2011 Jul
• Collagen-induced Platelet Activation In Vitro Increases Plasma Catecholamine Concentration.
  Smith, C. C., Prichard, B. N., Betteridge, D. J.> ;Platelets. 1992
• An Examination of Some Factors which Influence the Stability of in Vitro Platelet Responses.
  Alarayyid, N. A., Graham, B. R., Ferdous, A. H., Betteridge, D. J., Prichard, B. N., Smith, C. C.> ;Platelets. 1994
• Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
  Tam, X. H., Shiu, S. W., Leng, L., Bucala, R., Betteridge, D. J., Tan, K. C.> ;Clin Sci. 2011 Jan
• All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.
  Neil, H. A., Cooper, J., Betteridge, D. J., Capps, N., McDowell, I. F., Durrington, P. N., Seed, M., Mann, J. I., Humphries, S. E.> ;Atherosclerosis. 2010 Aug
• Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.
  Schernthaner, G., Barnett, A. H., Betteridge, D. J., Carmena, R., Ceriello, A., Charbonnel, B., Hanefeld, M., Lehmann, R., Malecki, M. T., Nesto, R., Pirags, V., Schee...> ;Diabetologia. 2010 Jul
• Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).
  Scheen, A. J., Tan, M. H., Betteridge, D. J., Birkeland, K., Schmitz, O., Charbonnel, B.> ;Diabet Med. 2009 Dec
• Join now to see all